Cefpimizole
![]() | |
Systematic (IUPAC) name | |
---|---|
2-[1-([(6R,7R)-2-carboxy-7-([(2R)-2-[(5-carboxy1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number |
84880-03-5 ![]() |
ATC code | none |
PubChem | CID 11765031 |
ChemSpider |
61863 ![]() |
UNII |
24S58UHU7N ![]() |
KEGG |
D03427 ![]() |
ChEMBL |
CHEMBL2103902 ![]() |
Chemical data | |
Formula | C28H26N6O10S2 |
Molar mass | 670.67 g/mol |
| |
| |
![]() ![]() |
Cefpimizole (INN) is a third-generation cephalosporin antibiotic.
References
- Hara K, Shimada J (June 1987). "[New antimicrobial agent series XXI: Cefpimizole]". Jpn J Antibiot (in Japanese) 40 (6): 1108–22. PMID 3312705.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.